Skip to main content

A PHASE Ib DOSE-ESCALATION AND DOSEEXPANSION STUDY EVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF VENETOCLAX IN COMBINATIONWITH ATEZOLIZUMAB, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH UNTREATED EXTENSIVE-STAGE SMALL CELL LU

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

July 20, 2020

End Date

December 15, 2023
 

Administered By

Duke Cancer Institute

Awarded By

Genentech, Inc.

Start Date

July 20, 2020

End Date

December 15, 2023